¼¼°èÀÇ À̵¿½Ä ȯÀÚ °Ý¸® ½ÃÀå º¸°í¼­ : Á¦Ç°º°, ±â´Éº°, Áغñº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Portable Patient Isolation Market Report by Product (Pod/Bag Based, Room-based), Functionality (Single-Use, Reusable), Readiness (Instant, Non-Instant), End User (Healthcare, Defense, and Others), and Region 2025-2033
»óǰÄÚµå : 1636307
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 134 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,221,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,628,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,036,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À̵¿½Ä ȯÀÚ °Ý¸® ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 4,820¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 1¾ï 2,850¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â°£ 10.95%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. Àü¿°º´ ¹× ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿ø°ÝÁö Àç³­ Áö¿ª¿¡¼­ÀÇ Á¦Ç° ¼ö¿ä Áõ°¡, ÀÇ·á °ü±¤ÀÇ Å« ÆøÀÇ ¼ºÀå µîÀÌ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.

À̵¿½Ä ȯÀÚ °Ý¸®´Â Àü¿°º´ È®»êÀ» ¹æÁöÇϱâ À§ÇØ Àü¿°º´ ȯÀÚ¸¦ °Ý¸®ÇÏ´Â ½Ã½ºÅÛ ¶Ç´Â ÀåÄ¡¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¿ÜºÎ ȯ°æÀ¸·ÎºÎÅÍ ¹ÐÆóµÇ°í À½¾Ð ȯ±â, °ø±â ¿©°ú ¹× UV-C »ì±Õ ±â´ÉÀ» °®Ãá ÀÎŬ·ÎÀú ¶Ç´Â è¹ö·Î ±¸¼ºµË´Ï´Ù. ÀÌ·¯ÇÑ ÀÎŬ·ÎÀú´Â ÀϹÝÀûÀ¸·Î È­ÇÐ ¹°Áú¿¡ ³»¼ºÀÌ ÀÖ°í ½±°Ô ¼Òµ¶ÇÒ ¼ö ÀÖ´Â ÇÃ¶ó½ºÆ½ ¶Ç´Â ±Ý¼ÓÀ¸·Î ¸¸µé¾îÁý´Ï´Ù. µ¶¸³ÀûÀ̰í ÈÞ´ë °¡´ÉÇÑ À̵¿½Ä ȯÀÚ °Ý¸® À¯´ÖÀº Àӽà ½Ã¼³, ºñ»ó ´ëÀÀ »óȲ ¹× ¿ø°ÝÁö¿¡¼­ »ç¿ëÇϱ⿡ ÀÌ»óÀûÀÔ´Ï´Ù. ¾ÈÀüÇϰí ÅëÁ¦µÈ ȯ°æÀ» ÅëÇØ ÀÇ·áÁøÀº ÀڽŰú ŸÀÎÀ» °¨¿° À§Çè¿¡ ³ëÃâ½ÃŰÁö ¾Ê°í °¨¿°µÈ ȯÀÚ¿¡°Ô ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖÀ¸¸ç, °¨¿°¿¡ ³ëÃâµÈ ¹«Áõ»ó ȯÀÚ¸¦ °Ý¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½±°Ô ÈÞ´ëÇÒ ¼ö ÀÖ°í ºñ»ó½Ã¿¡µµ ½±°Ô ¹èÄ¡ÇÒ ¼ö ÀÖ¾î Àç³­ ±¸È£ Ȱµ¿ ¹× ±âŸ À§±â »óȲ¿¡ ÀûÇÕÇÕ´Ï´Ù.

À̵¿½Ä ȯÀÚ °Ý¸® ½ÃÀå µ¿Çâ :

¼¼°è ½ÃÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ¼ö¸¹Àº °¨¿°¼º Áúȯ°ú Àü¿°º´ÀÇ ¹ß»ý·ü Áõ°¡ÀÔ´Ï´Ù. ÀÌ´Â Äڷγª19 ÆÒµ¥¹ÍÀÇ ¹ß»ý°ú Àü¿°¼ºÀÌ °­ÇÑ Äڷγª¹ÙÀÌ·¯½ºÀÇ ¼ö¸¹Àº º¯Á¾ ÃâÇö¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó ¿ø°ÝÁö Àç³­ Áö¿ª¿¡¼­ À̵¿½Ä ȯÀÚ °Ý¸® ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå¿¡ Ȱ·ÂÀ» ºÒ¾î³Ö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á °ü¸® ½Ã½ºÅÛÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú ÀÇ·á ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ È®Àå°ú ÇÔ²² ÀÇ·á ¼­ºñ½º¸¦ º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. À̿ʹ º°µµ·Î, ÀÇ·á °ü±¤ÀÇ ´ëÆøÀûÀÎ Áõ°¡, ƯÈ÷ ÀÇ·á ¼­ºñ½º°¡ Àú·ÅÇÑ ½ÅÈï ±¹°¡¿¡¼­ ÀÇ·á °ü±¤°´¿¡°Ô Àü¹®ÀûÀÎ Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ ÀÌ·¯ÇÑ À¯´ÖÀÇ ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°ÝÀÇ·á¿Í ¸¸¼ºÁúȯÀÚÀÇ ÀçÅÃÀÇ·á°¡ È®»êµÇ¸é¼­ ¿ø°ÝÀÇ·á¿Í ÀçÅà Àü¹® Áø·áÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå Ȱ¼ºÈ­·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á½Ã¼³ÀÇ º´»ó ºÎÁ·À¸·Î ÀÎÇØ À̵¿½Ä ȯÀÚ °Ý¸®º´½Ç ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ±âŸ ½ÃÀå È®´ë ¿äÀÎÀ¸·Î´Â ÀÇ·áºñ Áõ°¡, °¨¿° °ü¸® °­È­, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ R&D Ȱµ¿ µîÀÌ ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ À̵¿½Ä ȯÀÚ °Ý¸® ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ½ÃÀå ºÐ¼® : ±â´Éº°

Á¦8Àå ½ÃÀå ºÐ¼® : Áغñº°

Á¦9Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀΰú ±âȸ

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global portable patient isolation market size reached USD 48.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 128.5 Million by 2033, exhibiting a growth rate (CAGR) of 10.95% during 2025-2033. The rising prevalence of infectious and chronic diseases, the augmenting product demand in remote disaster-stricken regions, and considerable growth in medical tourism represent some of the key factors driving the market.

Portable patient isolation refers to a system or device that is designed to isolate patients suffering from infectious diseases to prevent the spread of such diseases. The system comprises an enclosure or chamber that is sealed from the outside environment and equipped with negative pressure ventilation, air filtration, and UV-C sterilization. These enclosures are typically made of plastic or metal, which is resistant to chemicals and easy to sanitize. Self-contained and portable, portable patient isolation units are ideal for use in temporary facilities, emergency response situations, and remote locations. A safe and controlled environment allows healthcare workers to provide medical treatment to infected patients without putting themselves or others at risk of infection, as well as to quarantine asymptomatic patients who are exposed to infectious diseases. As they are easily transportable and deployable in emergency situations, they are ideal for disaster relief efforts and other crisis situations.

Portable Patient Isolation Market Trends:

The global market is primarily driven by the rising incidences of numerous infectious and contagious diseases. This can be attributed to the outbreak of the COVID-19 pandemic and emergence of numerous variants of the highly infectious coronavirus. In line with this, the augmenting demand for portable patient isolation units in remote disaster-stricken regions is providing an impetus to the market. Moreover, continual technological advancements in medical management systems, along with the rapid expansion of healthcare infrastructure, are making healthcare services more accessible. Apart from this, considerable rise in medical tourism, particularly in developing countries with more affordable healthcare services, is resulting in a higher uptake of these units to provide specialized care for medical tourists. Furthermore, the increasing prevalence of telemedicine and home healthcare for patients with chronic disease is leading to a higher adoption of remote medical care and specialized consultations in the home setting, thereby fueling the market. Additionally, the growing usage of portable patient isolation units in cases of bed shortage in healthcare facilities is creating a positive outlook for the market. Some of the other factors contributing to the market include the rising medical expenditure, an enhanced focus on infection control, and extensive research and development (R&D) activities conducted by key players.

Key Market Segmentation:

Product Insights:

Functionality Insights:

Readiness Insights:

End User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Portable Patient Isolation Market

6 Market Breakup by Product

7 Market Breakup by Functionality

8 Market Breakup by Readiness

9 Market Breakup by End User

10 Market Breakup by Region

11 Drivers, Restraints, and Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â